Gene · 9547
Papers2,447
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,447
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MYL9 expressed in cancer-associated fibroblasts regulate the immune microenvironment of colorectal cancer and promotes tumor progression in an autocrine manner. | J Exp Clin Cancer Res | 2023 | 37926835 | PubTator, text mining | PubMed |
| Microglia in pediatric brain tumors: The missing link to successful immunotherapy. | Cell Rep Med | 2023 | 37924816 | PubTator, text mining | PubMed |
| T cell biology in neuromuscular disorders: a focus on Duchenne Muscular Dystrophy and Amyotrophic Lateral Sclerosis. | Front Immunol | 2023 | 37920473 | PubTator, text mining | PubMed |
| Prevention of severe lung immunopathology associated with influenza infection through adeno-associated virus vector administration. | Lab Anim Res | 2023 | 37904257 | PubTator, text mining | PubMed |
| GAD1 contributes to the progression and drug resistance in castration resistant prostate cancer. | Cancer Cell Int | 2023 | 37904122 | PubTator, text mining | PubMed |
| Innate Immunity in Autoimmune Thyroid Disease during Pregnancy. | Int J Mol Sci | 2023 | 37895126 | PubTator, text mining | PubMed |
| New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations. | Cancers (Basel) | 2023 | 37894445 | PubTator, text mining | PubMed |
| The Value of CXCL1, CXCL2, CXCL3, and CXCL8 as Potential Prognosis Markers in Cervical Cancer: Evidence of E6/E7 from HPV16 and 18 in Chemokines Regulation. | Biomedicines | 2023 | 37893029 | PubTator, text mining | PubMed |
| Tumor Progression from a Fibroblast Activation Protein Perspective: Novel Diagnostic and Therapeutic Scenarios for Colorectal Cancer. | Diagnostics (Basel) | 2023 | 37892020 | PubTator, text mining | PubMed |
| Complementary Activities of Host Defence Peptides and Antibiotics in Combating Antimicrobial Resistant Bacteria. | Antibiotics (Basel) | 2023 | 37887219 | PubTator, text mining | PubMed |
| White Adipose Tissue Heterogeneity in the Single-Cell Era: From Mice and Humans to Cattle. | Biology (Basel) | 2023 | 37886999 | PubTator, text mining | PubMed |
| SLC7A11, a potential immunotherapeutic target in lung adenocarcinoma. | Sci Rep | 2023 | 37880315 | PubTator, text mining | PubMed |
| Healthy aging-would cytotoxic T lymphocytes stand out? | Cell Death Discov | 2023 | 37875495 | PubTator, text mining | PubMed |
| A Specialized Epithelial Cell Type Regulating Mucosal Immunity and Driving Human Crohn's Disease. | bioRxiv | 2023 | 37873404 | PubTator, text mining | PubMed |
| A prognostic mathematical model based on tumor microenvironment-related genes expression for breast cancer patients. | Front Oncol | 2023 | 37860187 | PubTator, text mining | PubMed |
| CXCL chemokines-mediated communication between macrophages and BMSCs on titanium surface promotes osteogenesis via the actin cytoskeleton pathway. | Mater Today Bio | 2023 | 37859997 | PubTator, text mining | PubMed |
| Single-cell transcriptomics provide insight into metastasis-related subsets of breast cancer. | Breast Cancer Res | 2023 | 37858183 | PubTator, text mining | PubMed |
| Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker. | Eur J Med Res | 2023 | 37848933 | PubTator, text mining | PubMed |
| CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer. | Sci Rep | 2023 | 37848726 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts in early-stage lung adenocarcinoma correlate with tumor aggressiveness. | Sci Rep | 2023 | 37848457 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9547/papers?page=15